Menü mobile menu

Mitarbeiter

Mostafa Samak

Promovierender

Versuchstierkunde

+49 551 3851-125

MSamak(at)dpz.eu

B1.13

Kellnerweg 4
37077 Göttingen

+49 17637636301
  • Gestörte Mikrozirkulation bei Diabetes mellitus

  • Diabetische Kardiomyopathie

  • Endothelbiologie

Ausbildung

  • Masterstudium in Molekulare Medizin - Georg-August Universität Göttingen

  • Bachelorstudium in pharmazeutische Wissenschaften - Ägypten

 

  • Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
  • Deutsche Gesellschaft für Kardiologie (DGK)
  • European Vascular Biology Organization (EVBO)
  1. Samak M et al: Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes. Biomedicines, 2021 Dec 28; 10(1):58. doi: 10.3390/biomedicines10010058.

  2. Samak M and Hinkel R: Stem Cells in Cardiovascular Medicine: Historical Overview and Future Prospects. Cells, 2019 Nov 27; 8(12):1530. doi: 10.3390/cells8121530.

  3. Samak M et al: Total Arterial Revascularization: Bypassing Antiquated Notions to Better Alternatives for Coronary Artery Disease. Med Sci Monit Basic Res, 2016 Oct 4; 22:107-114. doi: 10.12659/msmbr.901508.

  4. Samak M et al:  Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis. Med Sci Monit Basic Res, 2016 Jul 23; 22:75-79. doi: 10.12659/MSMBR.900437.

  5. Samak M et al: Past and Present of Total Artificial Heart Therapy: A Success Story. Med Sci Monit Basic Res, 2015 Sep 7; 21:183-90. doi: 10.12659/MSMBR.895418.

  6. Fatullayev J*, Samak M* et al: Non-Heart Beating Donor Heart Transplantation: Breaking the Taboo. Med Sci Monit Basic Res, 2015 Jul 15; 21:153-6. doi: 10.12659/MSMBR.894985. *Equal contribution

  7. Fatullayev J, Samak M et al: Continuous-Flow Left Ventricular Assist Device Thrombosis: A Danger Forseen is a Danger Avoided. Med Sci Monit Basic Res, 2015 Jul 1; 21:141-144. doi: 10.12659/MSMBR.894840.

Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes.

Download (8 MB)

Zurück zur Übersicht